N-(2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PROPIONAMIDE, 95%, 1g

3-Hydroxy-2-(toluene-4-sulfonylamino)-butyric acid, 100mg

2,6-Dihydroxyacetophenone, min. 98%, 10 g, plastic packaging.

Imidazo[1,2-b]pyridazin-8(5H)-one, 98%, 100mg

2'-Anilino-6'-(dibutylamino)-3'-methylfluoran>98.0%(HPLC)25g

(2S,4R)-1-((S)-23-Azido-2-(tert-butyl)-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98%, 100mg

5-HYDROXY-7-METHOXY-2-METHYL-4H-CHROMEN-4-ONE, 95.0%, 1g

Propyl benzoate, 95.0%, 1g

4-Methyl-1-piperazinecarbonyl chloride hydrochloride, 95.0%, 10g

2-CHLORO-4-(ISO-PROPYL)-6-AMINO-1,3,5-TRIAZINE, 95.0%, 250mg

2-Vinylpyridine (stabilised with tert-Butylcatechol), 95.0%, 1g

1,2-DImyristoyl-rac-glycero-3-phosphocholine, 5g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 5mg